You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 21, November 27, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Women's Health
 •Women's Health, Other
 •Oncology
 •Breast Cancer
 •Alert me on articles by topic

Longitudinal Study on the Role of Body Size in Premenopausal Breast Cancer

Karin B. Michels, ScD, PhD; Kathryn L. Terry, ScD; Walter C. Willett, MD, DrPH

Arch Intern Med. 2006;166:2395-2402.

Background  A high body mass index (BMI) has been related to a reduced risk of breast cancer in premenopausal women. The mechanisms underlying this association have not been elucidated.

Methods  We explored whether factors affecting ovulation may explain the inverse association between BMI (calculated as weight in kilograms divided by the square of height in meters) and breast cancer in 113 130 premenopausal participants in the Nurses' Health Study II. During 1 225 520 person-years of prospective follow-up between 1989 and 2003, 1398 incident cases of invasive breast cancer were diagnosed. Weight, height, ovulatory infertility, menstrual cycle patterns, and a multitude of covariates were assessed throughout follow-up. Cox proportional hazards regression was used to compute hazard ratios and 95% confidence intervals (CIs).

Results  We observed a significant linear inverse trend between current BMI and breast cancer incidence (P<.001) that was not explained by menstrual cycle characteristics or infertility due to an ovulatory disorder (covariate-adjusted hazard ratio for breast cancer in women with a BMI ≥30 vs 20.0-22.4, 0.81; 95% CI, 0.68-0.96). We found BMI at age 18 years to be the strongest predictor of breast cancer incidence (covariate-adjusted hazard ratio for breast cancer in women with a BMI at age 18 years ≥27.5 vs 20.0-22.4, 0.57; 95% CI, 0.41-0.81).

Conclusions  Body size during the early phases of adult life seems to be particularly important in the development of premenopausal breast cancer. Factors other than anovulation are likely to mediate the protection conferred by a high BMI.


Author Affiliations: Department of Obstetrics and Gynecology, Obstetrics and Gynecology Epidemiology Center (Drs Michels and Terry), and Department of Medicine, Channing Laboratory (Drs Michels, Terry, and Willett), Brigham and Women's Hospital, Harvard Medical School; and Departments of Epidemiology (Drs Michels and Willett) and Nutrition (Dr Willett), Harvard School of Public Health; Boston, Mass.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relative Weight at Age 12 and Risk of Postmenopausal Breast Cancer
Bardia et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:374-378.
ABSTRACT | FULL TEXT  

A Prospective Study of Body Size and Breast Cancer in Black Women
Palmer et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1795-1802.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.